Status:
ENROLLING_BY_INVITATION
Development of a Risk Assessment Tool for Incontinence-associated Dermatitis (IAD): a Cohort Study on the Predictive Performance of Risk Factors for IAD
Lead Sponsor:
Örebro University, Sweden
Collaborating Sponsors:
University Ghent
Conditions:
Incontinence Associated Dermatitis
Eligibility:
All Genders
18+ years
Brief Summary
Objective: The primary goal of this prospective cohort study is to collect data on specific factors, including age, sex, stool consistency, etc. and assess their association with the development of IA...
Detailed Description
Problem Statement: Incontinence-Associated Dermatitis (IAD) is a type of irritant contact dermatitis caused by prolonged skin exposure to urine and/or feces. It commonly affects individuals with inco...
Eligibility Criteria
Inclusion
- The patient or their legally authorized representative signed informed consent.
- The patient is aged 18 years or older.
- The patient suffers from incontinence\* (urinary, faecal, double incontinence).
- The patient is free of IAD at inclusion. \*Incontinence is defined as involuntary loss of urine and/or stool.
Exclusion
- Patients admitted to emergency departments, paediatric units, maternity units, psychiatric units, and palliative care units.
- Patients who are receiving end-of-life care.
Key Trial Info
Start Date :
May 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
1037 Patients enrolled
Trial Details
Trial ID
NCT06978751
Start Date
May 13 2025
End Date
May 1 2026
Last Update
August 12 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Sint-Lucas
Ghent, Belgium
2
University Hospital Ghent
Ghent, Belgium
3
Sint-Jozefskliniek
Izegem, Belgium
4
AZ Groeninge
Kortrijk, Belgium